| SC 13G/A | 2024-02-14 | 1 MAIN CAPITAL MANAGEMENT, LLC | ENZO BIOCHEM INC | 2,500,000 | 5.0% | EDGAR |
| SC 13G/A | 2024-02-13 | RENAISSANCE TECHNOLOGIES LLC | ENZO BIOCHEM INC | 2,479,195 | 4.9% | EDGAR |
| SC 13G | 2023-09-11 | 1 MAIN CAPITAL MANAGEMENT, LLC | ENZO BIOCHEM INC | 2,874,125 | 5.8% | EDGAR |
| SC 13D/A | 2023-07-24 | LABORATORY CORP OF AMERICA HOLDINGS | ENZO BIOCHEM INC | 0 | 0.0% | EDGAR |
| SC 13D/A | 2023-05-10 | Radoff Bradley Louis | ENZO BIOCHEM INC | 430,000 | 9.3% | EDGAR |
| SC 13D | 2023-03-27 | LABORATORY CORP OF AMERICA HOLDINGS | ENZO BIOCHEM INC | 4,862,730 | 9.8% | EDGAR |
| SC 13G/A | 2023-02-13 | RENAISSANCE TECHNOLOGIES LLC | ENZO BIOCHEM INC | 2,813,964 | 5.8% | EDGAR |
| SC 13D/A | 2023-01-23 | Wolf James G. | ENZO BIOCHEM INC | - | 10.1% | EDGAR |
| SC 13D/A | 2022-11-23 | Wolf James G. | ENZO BIOCHEM INC | 4,168,500 | 8.6% | EDGAR |
| SC 13D/A | 2022-10-26 | Wolf James G. | ENZO BIOCHEM INC | 4,114,500 | 8.4% | EDGAR |
| SC 13D/A | 2022-03-25 | Roumell Asset Management, LLC | ENZO BIOCHEM INC | 2,426,771 | 5.0% | EDGAR |
| SC 13G/A | 2022-02-14 | RENAISSANCE TECHNOLOGIES LLC | ENZO BIOCHEM INC | 3,094,764 | 6.4% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | ENZO BIOCHEM INC | 1,783,048 | 3.7% | EDGAR |
| SC 13G/A | 2022-01-18 | Evermore Global Advisors, LLC | ENZO BIOCHEM INC | 0 | 0.0% | EDGAR |
| SC 13D/A | 2022-01-04 | Radoff Bradley Louis | ENZO BIOCHEM INC | 400,000 | 8.9% | EDGAR |
| SC 13D/A | 2021-12-27 | Radoff Bradley Louis | ENZO BIOCHEM INC | 400,000 | 8.9% | EDGAR |
| SC 13D/A | 2021-11-15 | Wolf James G. | ENZO BIOCHEM INC | 3,262,500 | 6.7% | EDGAR |
| SC 13D/A | 2021-10-28 | Harbert Discovery Fund, LP | ENZO BIOCHEM INC | 1,763,493 | 3.6% | EDGAR |
| SC 13D/A | 2021-10-22 | Radoff Bradley Louis | ENZO BIOCHEM INC | 400,000 | 7.5% | EDGAR |
| SC 13D | 2021-10-06 | Radoff Bradley Louis | ENZO BIOCHEM INC | 309,401 | 6.4% | EDGAR |